doxorubicin hydrochloride, Liposomal
DOXORUBICIN HYDROCHLORIDE
INTRAVENOUS
HUMAN PRESCRIPTION DRUG
doxorubicin hydrochloride, Liposomal is an FDA drug label for the active ingredient DOXORUBICIN HYDROCHLORIDE manufactured by Baxter Healthcare Corporation administered by INTRAVENOUS. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231219.
- Generic name
- DOXORUBICIN HYDROCHLORIDE
- Manufacturer
- Baxter Healthcare Corporation
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Dosage form
- N/A
- NDC
- 0338-9581
- Application
- N/A
- Label effective
- 20231219
Indications & Usage
Not available.
Dosage & Administration
Not available.
Contraindications
Not available.
Warnings
Not available.
Adverse Reactions
Not available.